Xeris Biopharma Holdings
XERS
XERS
70 hedge funds and large institutions have $42.9M invested in Xeris Biopharma Holdings in 2021 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 24 increasing their positions, 23 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
63% less capital invested
Capital invested by funds: $115M → $42.9M (-$71.9M)
74% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 31
Holders
70
Holding in Top 10
–
Calls
$5.3M
Puts
$1.24M
Top Buyers
| 1 | +$1.3M | |
| 2 | +$453K | |
| 3 | +$427K | |
| 4 |
Lazard Asset Management
New York
|
+$336K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$321K |
Top Sellers
| 1 | -$26.7M | |
| 2 | -$7.39M | |
| 3 | -$2.68M | |
| 4 |
Brown Advisory
Baltimore,
Maryland
|
-$1.22M |
| 5 |
D.E. Shaw & Co
New York
|
-$1.06M |